PRICE T ROWE ASSOCIATES INC /MD/ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$478
+19.5%
159,290
-1.9%
0.00%
Q2 2023$400
-1.0%
162,436
-9.0%
0.00%
Q1 2023$404
-38.2%
178,440
-4.8%
0.00%
Q4 2022$654
-100.0%
187,459
-4.6%
0.00%
-100.0%
Q3 2022$7,278,000
+127.1%
196,556
+16.5%
0.00%
Q2 2022$3,205,000
-24.6%
168,757
+7.1%
0.00%
Q1 2022$4,253,000
+1915.6%
157,565
+1855.6%
0.00%
Q3 2021$211,000
-95.8%
8,057
-93.8%
0.00%
-100.0%
Q4 2019$5,049,000129,4610.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders